Top journals
Frequent coauthors
- van der Zee AGJ 2
- Bernards R 2
- Hijmans EM 2
- Itamochi H 2
- Berns K 2
- Wisman GBA 2
- Caumanns JJ 2
- Gennissen AMC 2
- Crijns AP 1
- Beijersbergen RL 1
2018
Current treatment for advanced stage ovarian clear cell cancer is severely hampered by a lack of effective systemic therapy options, leading to a poor outlook for these patients. Sequencing studies revealed that ARID1A is mutated in over 50…
2018
Purpose: Advanced-stage ovarian clear cell carcinoma (OCCC) is unresponsive to conventional platinum-based chemotherapy. Frequent alterations in OCCC include deleterious mutations in the tumor suppressor ARID1A and activating mutations in t…
2008
Ovarian cancer is the most frequent cause of death from gynaecological cancer in the Western world. Current prognostic factors do not allow reliable prediction of response to chemotherapy and survival for individual ovarian cancer patients.…